Linkage mapping for hypertension susceptibility genes

Current Hypertension Reports

Volumn 1, Issue 1, 1999, Pages 15-24

  Kato, Norihiro ^a   Julier, Cécile ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CHROMOSOME MAP; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; HYPERTENSION; RAT; REVIEW;

ANIMALS; CHROMOSOME MAPPING; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HYPERTENSION; RATS;

EID: 0033068864     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-999-0069-7     Document Type: Article

References (66)

1. Mongeau JG: Heredity and blood pressure. Semin Nephrol 1989, 9:208-216.
2. Risch N: Linkage strategies for genetically complex traits. [II. The power of affected relative pairs.] Am J Hum Genet 1990, 46:229-241.
3. Ayman D: Heredity in arteriolar (essential) hypertension. Arch Intern Med 1934, 53:792-802.
4. Williams RR, Hunt SC, Hasstedt SJ, et al.: Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Hypertension 1991, 18:I- 29-I-37.
5. Brown MJ: The causes of essential hypertension. Br J Clin Pharmacol 1996, 42:21-27.
6. Bell JI, Lathrop GM: Multiple loci for multiple sclerosis. Nat Genet1996, 13:377-378.
7. Parkes M, Satsangi J, Lathrop GM, et al.: Susceptibility loci in inflammatory bowel disease. Lancet 1996, 348:1588.
8. Weeks DE, Lathrop GM: Polygenic disease: method for mapping complex disease traits. TIG 1995, 11:513-519.
9. Satsangi J, Parkes M, Louis E, et al:. Two stage genome-wide search in inflammatory bowel disease - evidence for susceptibility loci on chromosome 3, 7, and 12. Nat Genet 1996, 14:199-202.
10. Haseman JK, Elston RC: The investigation of linkage between a quantitative trait and a marker locus. Behav Genet 1972, 2:3-10.
11. Goldger DE: Multipoint analysis of quantitative genetic variation. Am J Hum Genet 1990, 47:957-967.
12. Schork NJ: Extended multipoint identity-by-decent analysis of human quantitative traits: efficacy, power, and modelling considerations. Am J Hum Genet 1993, 53:1306-1319. (Pubitemid 23346230)
13. Amos CI: Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 1994, 54:535-543. (Pubitemid 24068235)
14. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995, 11:241-247.
15. Julier C, Delepine M, Keavney B, et al.: Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome. 10. Hum Mol Genet 1997, 6:2077-2085.
16. Schuster H, Wienker TF, Bahring S, et al.: Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12.Nat Genet 1996, 13:98-100.
17. Schiffrin EL: Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension 1995, 25:1135-1143.
18. Dominczak A, Bohr DF: Nitric oxide and its putative role in hypertension. Hypertension 1995, 25:1202-1211.
19. Ishimizu T, Kojima M, Kangawa K, et al.: Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994, 203:631-639. (Pubitemid 24281141)
20. Urata H, Kinoshita A, Perez DM, et al.: Cloning of the gene and cDNA for human heart chymase. J Biol Chem 1991, 266:17173-17179. (Pubitemid 21907921)
21. Dib C, Fauré S, Fizames C, et al.: A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature 1996, 380:152-154. (Pubitemid 26085878)
22. Concannon P, Gogolin-Ewens KJ, Hinds DA, et al.: A secondgeneration screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998, 19:292- 296. (Pubitemid 28309347)
23. Mein CA, Esposito L, Dunn MG, et al.: A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998, 19:297-300. (Pubitemid 28309348)
24. Hanis C, Boerwinkle E, Chakraborty R et al.: A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a susceptibility locus on chromosome 2. Nat Genet 1996, 13:161-166. (Pubitemid 26000435)
25. Wu D-A, Bu X, Warden CH, et al.: Quantitative trait locus mapping of human blood pressure to a genetic region at or near the lipoprotein lipase gene locus on chromosome 8p22. J Clin Invest 1996, 97:2111-2118. (Pubitemid 26143966)
26. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al.: Molecular basis of human hypertension. Cell 1992, 71:169 180.
27. Jeunemaitre X, Lifton RP, Hunt SC, et al.: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1992, 1:72-75.
28. Bonnardeaux A, Davies E, Jeunemaitre X, et al.: Angiotensin II type 1 receptor gene polymorphisms in essential hypertension. Hypertension 1994, 24:63-69. (Pubitemid 24195405)
29. Jeunemaitre X, Rigat B, Charru A, et al.: Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992, 88:301-306.
30. Bonnardeaux A, Nadaud S, Charru A, et al.: Lack of evidence for linkage of the endothelial nitric oxide synthase gene to essential hypertension. Circulation 1995, 91:96-102.
31. Hunt SC, Williams CS, Sharma AM, et al.: Lack of linkage between the endothelial nitric oxide synthase gene and hypertension. J Hum Hyperten 1996, 10:27-30. (Pubitemid 26057292)
32. Lifton RP, Hunt SC, Williams RR, et al.: Exclusion of the Na+- H+ antiporter as a candidate gene in human essential hypertension. Hypertension 1991, 17:8-14.
33. Nabika T, Bonnardeaux A, James M, et al.: Evaluation of the SA locus in human hypertension. Hypertension 1995, 25:6-13.
34. Cusi D, Barlassina C, Azzani T, et al.: Polymorphisms of a- adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349:1353-1357. (Pubitemid 27197537)
35. Caulfield M, Lavender P, Farrall M, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633. (Pubitemid 24166862)
36. Caulfield M, Lavender P, Newell-Price J, et al.: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
37. Atwood LD, Kammerer CM, Samollow PB, et al.: Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension 1997, 30:326-330. (Pubitemid 27446088)
38. Niu T, Xu X, Rogus J, et al.: Angiotensinogen gene and hypertension in Chinese. J Clin Invest 1998, 101:188-194. (Pubitemid 28058918)
39. Brand E, Chatelain N, Keavney B, et al.: Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension 1998, 31:725-729. (Pubitemid 28108568)
40. Jeunemaitre X, Inoue I, Williams C, et al.: Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 1997, 60:1448-1460. (Pubitemid 27258077)
41. Kim HS, Krege JH, Kluckman KD, et al.: Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A 1995, 92:2735-2739.
42. Hamet P, Pausova Z, Adarichev V, et al.: Hypertension: genes and environment. J Hypertens 1998, 16:397-418. (Pubitemid 28195849)
43. O'Donnell CJ, Lindpaintner K, Larson MG, et al.: Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not in women in the Framingham Heart Study. Circulation 1998, 97:1766-1772.
44. Fornage M, Amos CI, Kardia S, et al.: Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 1998, 97:1773-1779.
45. Tiret L, Rigat B, Visvikis S, et al.: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
46. McKenzie CA, Julier C, Forrester T, et al.: Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995, 57:1426-1435.
47. Keavney B, McKenzie C, Connell J, et al.: Measured haplotype analysis of the angiotensin-1 converting enzyme (ACE) gene. Hum Mol Genet 1998, in press.
48. Krege JH, Kim HS, Moyer JS, et al.: Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 1997, 29:150-157. (Pubitemid 27074036)
49. Samani NJ, Thompson JR, O'Toole L, et al.: A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 1996, 94:708-712. (Pubitemid 26289226)
50. Soubrier F: Blood pressure gene at the angiotensin-converting enzyme locus: chronicle of a gene foretold. Circulation 1998, 97:1763-1765.
51. Mansfield TA, Simon DB, Farfel Z, et al.: Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 1997, 16:202-205. (Pubitemid 27240623)
52. Bianchi G, Tripodi G, Casari G, et al.: Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci U S A 1994, 91:3999-4003. (Pubitemid 24139560)
53. Kato N, Sugiyama T, Nabika T, et al.: Lack of association between the a-adducin locus and essential hypertension in the Japanese population. Hypertension 1998, 31:730-733. (Pubitemid 28108569)
54. Krushkai J, Xiong M, Ferrell R, et al.: Linkage and association of adrenergic and dopamine receptor genes in the distal portion of the long arm of chromosome 5 with systolic blood pressure variation. Hum Mol Genet 1998, 7:1379-1383. (Pubitemid 28429916)
55. Risch NJ, Zhang H: Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995, 268:1584- 1589.
56. Spielman RS, Ewens WJ: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996, 59:983-989. (Pubitemid 26346336)
57. Lifton RP: Molecular genetics of human blood pressure variation. Science 1996, 272:676-680. (Pubitemid 26000271)
58. Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11?-hydroxylase/ aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.Nature 1992, 355:262-265.
59. Mune T, Rogerson FM, Nikkila H, et al.: Human hypertension caused by mutations in the kidney isozyme of 11 ? -hydroxysteroid dehydrogenase. Nat Genet 1995, 10:394-399.
60. Li A, Tedde R, Krozowski ZS, et al.: Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess. Am J Hum Genet 1998, 63:370-37 .
61. Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle's syndrome: heritable human hypertension caused by mutations in the b subunit of the epithelial sodium channel. Cell 1994, 79:407-414. (Pubitemid 24346056)
62. Hansson JH, Nelson Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel g subunit: genetic heterogeneity of Liddle's syndrome. Nat Genet 1995, 11:76-82.
63. Tamura H, Schild L, Enomoto N, et al.: Liddle disease caused by a missense mutation of ? subunit of the epithelial sodium channel gene. J Clin Invest 1996, 97:1780-1784. (Pubitemid 26105488)
64. Melander O, Orho M, Fagerudd J, et al.: Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension 1998, 31:1118-1124. (Pubitemid 28191506)
65. Brand E, Kato N, Chatelain N, et al.: Structural analysis and evaluation of the 11 b -hydroxysteroid dehydrogenase type 2 (11-HSD2) gene in human essential hypertension. J Hypertens 1999, in press.
66. Baker E, Dong Y, Sagnella G, et al.: Association of hypertension with T594M mutation in b subunit of epithelial sodiu channels in black people resident in London. Lancet 1998, 351:1388-1392. (Pubitemid 28209996)